Notice of Proposed Sale · 144
Nuvalent, Inc.
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Nuvalent, Inc.
- Issuer CIK
- 0001861560
- SEC file number
- 001-40671
- Phone
- 8573577000
- Person for whose account securities are to be sold
- Alexandra Balcom
- Relationships to issuer
- Officer
- Street
- One Broadway, 14th floor
- City
- Cambridge
- State / country code
- MA
- Postal code
- 02142
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Class A Common | 22,860 | 2,823,896 | 73,562,661 | 07/01/2026 | NASDAQ | J.P. Morgan Securities LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- J.P. Morgan Securities LLC
- Street
- 270 Park Avenue
- Street (continued)
- 10th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10017
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Class A Common | 07/01/2026 | NQ Stock Options | Issuer | 22,860 | N | 07/01/2026 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Alexandra Balcom | Class A Common | 03/24/2026 | 11,430 | 1,094,401 |
| Alexandra Balcom | Class A Common | 03/25/2026 | 13,700 | 1,372,158 |
| Alexandra Balcom | Class A Common | 04/01/2026 | 11,430 | 1,202,555 |
| Alexandra Balcom | Class A Common | 05/01/2026 | 11,430 | 1,131,589 |
| Alexandra Balcom | Class A Common | 06/01/2026 | 11,430 | 1,128,083 |
Seller — prior-sale row 1, entry 1
- Name
- Alexandra Balcom
- Street
- One Broadway, 14th Floor
- City
- Cambridge
- State / country code
- MA
- Postal code
- 02142
Seller — prior-sale row 2, entry 1
- Name
- Alexandra Balcom
- Street
- One Broadway, 14th Floor
- City
- Cambridge
- State / country code
- MA
- Postal code
- 02142
Seller — prior-sale row 3, entry 1
- Name
- Alexandra Balcom
- Street
- One Broadway, 14th Floor
- City
- Cambridge
- State / country code
- MA
- Postal code
- 02142
Seller — prior-sale row 4, entry 1
- Name
- Alexandra Balcom
- Street
- One Broadway, 14th Floor
- City
- Cambridge
- State / country code
- MA
- Postal code
- 02142
Seller — prior-sale row 5, entry 1
- Name
- Alexandra Balcom
- Street
- One Broadway, 14th Floor
- City
- Cambridge
- State / country code
- MA
- Postal code
- 02142
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
The sales under this filing are from Cashless Option Exercises that will occur within 3 months from the date of this filing.
Notice signature
- Notice date
- 07/01/2026
- Signed
- /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Alexandra Balcom
- Plan adoption dates
- 12/23/2025
Company context
Nuvalent (NASDAQ: NUVL) is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, Nuvalent develops innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs.